Skip to main content
. 2020 May 18;20:229. doi: 10.1186/s12872-020-01491-4

Table 1.

Clinical features of enrolled patients

Bicuspid aortic stenosis (n = 33) Tricuspid aortic stenosis (n = 24) P-value
Female, n (%) 24 (72.73%) 8 (33.33%) 0.006
Age (years) 72.48 ± 5.62 74.38 ± 5.53 0.21
Height (m) 1.57 ± 0.08 1.61 ± 0.09 0.12
Weight (kg) 55.15 ± 9.88 59.69 ± 9.87 0.92
BMI (kg/m2) 22.13 ± 3.45 22.83 ± 3.23 0.44
STS-PROM (%) 6.50 (4.42–8.59) 8.26 (4.93–13.38) 0.09
Comorbidities
 Hypertension, n(%) 15 (45.45%) 7 (29.17%) 0.27
 Diabetes, n (%) 1 (3.03%) 3 (12.5%) 0.15
 Chronic lung disease, n (%) 18 (54.55%) 19 (79.17%) 0.09
 Coronary artery disease, n (%) 16 (48.48%) 10 (41.67%) 0.78
 Prior myocardial infarction, n (%) 0 0
 Prior percutaneous coronary intervention, n (%) 2 (6.06%) 3 (12.5%) 0.64
 Peripheral vascular disease, n (%) 20 (60.60%) 20 (83.3%) 0.08
 Chronic kidney disease, n (%) 6 (18.18%) 5 (20.83%) 0.99
Baseline echocardiography
 Left ventricular ejection fraction, % 53.73 ± 15.05 44.67 ± 14.19 0.025
 Transaortic Vmax, m/s 5.14 ± 0.78 4.57 ± 0.85 0.011
 Transaortic PGmean, mmHg 67.52 ± 21.99 55.79 ± 16.01 0.031
 LVM, g 265.35 ± 87.38 338.84 ± 98.46 0.004
 LVMI, g/m2 161.66 ± 48.78 197.66 ± 62.32 0.018
 Ascending aorta diameter, mm 40.50 ± 5.59 38.75 ± 4.32 0.21